Clinical Trials Directory

Trials / Completed

CompletedNCT01150552

Studies of Avian Influenza Transmission to Humans in Egypt

Prospective Studies of Avian Influenza Transmission to Humans in Egypt

Status
Completed
Phase
Study type
Observational
Enrollment
1,000 (actual)
Sponsor
St. Jude Children's Research Hospital · Academic / Other
Sex
All
Age
2 Years
Healthy volunteers
Accepted

Summary

The main focus of the study is: * To estimate seroprevalence of AI in poultry-exposed and non-exposed human populations. * To estimate the incidence of AI in poultry-exposed and non-exposed human populations. * To investigate risk factors associated with AI infections in occupationally-exposed poultry workers. The secondary objectives of the study: * To investigate patterns in transmission of AI to household contacts of AI clinical cases * To isolate AI viruses from acute cases * To monitor the pathogenicity and disease severity of AI viruses causing human infections

Detailed description

This 4-year prospective cohort study to compare individuals with occupational exposure to poultry with non-poultry exposed adult controls for evidence of incident and previous infections with AI viruses. At the start of this study, study staff will obtain informed consent, and a blood sample will be obtained from study volunteers to establish baseline levels of antibodies against avian influenza types H4-H12. Subjects will be interviewed regarding their exposures, medical history, and behaviors using a close-ended questionnaire specifically tailored for this study. After one year, study subjects will be interviewed again to note any changes in exposure variables. At this time, another blood sample will be obtained and tested for any changes in antibodies' levels. The same procedures will be repeated at the final visit after another year. Exposed individuals will be selected from rural areas where poultry is commonly raised. Non-exposed controls will be selected from urban neighborhoods in Cairo.

Conditions

Timeline

Start date
2010-06-01
Primary completion
2014-05-01
Completion
2014-05-01
First posted
2010-06-25
Last updated
2014-07-14

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT01150552. Inclusion in this directory is not an endorsement.